Aurora Cannabis (NASDAQ:ACB) Upgraded at TD Securities

TD Securities upgraded shares of Aurora Cannabis (NASDAQ:ACB) to a strong-buy rating in a report published on Thursday morning,Zacks.com reports.

Separately, TD Cowen began coverage on shares of Aurora Cannabis in a research note on Wednesday. They set a “buy” rating for the company.

Aurora Cannabis Trading Up 0.9 %

NASDAQ:ACB opened at $4.31 on Thursday. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $236.36 million, a price-to-earnings ratio of -5.67 and a beta of 1.86. The firm has a 50 day moving average of $5.00 and a 200 day moving average of $5.53.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of ACB. TD Asset Management Inc purchased a new position in Aurora Cannabis in the second quarter valued at about $255,000. Headlands Technologies LLC raised its holdings in Aurora Cannabis by 98.8% during the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock worth $346,000 after purchasing an additional 37,269 shares during the last quarter. Tidal Investments LLC boosted its position in Aurora Cannabis by 2.7% during the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after purchasing an additional 34,988 shares in the last quarter. Mackenzie Financial Corp purchased a new position in shares of Aurora Cannabis in the second quarter valued at $113,000. Finally, Toronto Dominion Bank raised its stake in shares of Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Institutional investors and hedge funds own 47.63% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.